1620 Investment Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8K Sell
574
-126
-18% -$5.08K 0.01% 398
2026
Q1
$23.4K Sell
700
-28
-4% -$1.17K 0.02% 381
2025
Q4
$33K Sell
728
-18
-2% -$659 0.02% 341
2025
Q3
$22.7K Sell
746
-1,559
-68% -$47.9K 0.02% 372
2025
Q2
$67.8K Buy
2,305
+35
+2% +$1.05K 0.05% 272
2025
Q1
$79.4K Buy
2,270
+58
+3% +$2.3K 0.06% 243
2024
Q4
$98.5K Hold
2,212
0.07% 222
2024
Q3
$96.4K Buy
2,212
+1,542
+230% +$58.1K 0.07% 234
2024
Q2
$18.1K Buy
+670
New +$19.4K 0.01% 407

Other funds holding OMCL

1620 Investment Advisors's OMCL Position: Q2 2026 in Review

1620 Investment Advisors reduced its Omnicell (OMCL) stake by 18% in Q2 2026, selling an estimated $5.08K and leaving 574 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #398.

1620 Investment Advisors first reported a position in OMCL in Q2 2024 and has held it in 9 quarters since. The position peaked at $98.5K in Q4 2024. 51 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • 1620 Investment Advisors held 574 shares of Omnicell worth $23.8K as of Q2 2026.
  • 1620 Investment Advisors sold 126 Omnicell shares in Q2 2026, an estimated $5.08K.
  • Omnicell made up 0.01% of 1620 Investment Advisors's portfolio in Q2 2026, its #398 holding.
  • 1620 Investment Advisors first reported a position in Omnicell in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's Omnicell position peaked at $98.5K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.